Presentation on the biosimilar Enoxaparin of ROVI


No votes yet
 
Related
ROVI informs on the impact of Covid 19 on the company’s activities
Laboratorios Farmacéuticos ROVI, S.A. (ROVI) reports that, since the beginning of the spread of Covid-19, the company has been executing...
6 min
02/04/2020
ROVI will donate a million surgical masks to the Ministry of Health
Since the beginning of the health crisis caused by the expansion of COVID-19, ROVI has been taking measures to ensure the continuity of its...
1 min
26/03/2020